The Role of Whole‐Exome Sequencing and Methylation Analysis in Untangling Complex Facioscapulo‐Humeral Muscular Dystrophy Cases
Clinical Genetics · 2026
DOI: 10.1111/cge.70044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, 2026. Verfasst von Francesca Torri und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Muscular Dystrophy, Facioscapulohumeral, DNA Methylation, Exome Sequencing, Genetic Predisposition to Disease. Die Arbeit nennt 42 Literaturangaben. Gefördert von: the Italian Ministry for University and Research (MUR), Ministero dell'Università e della Ricerca.
Abstract (Originalsprache)
Facioscapulo‐humeral muscular dystrophy is characterized by a distinctive phenotype, although a wide range of clinical expressions is observed, possibly reflecting different disease progression rates or complex genetic mechanisms. To date, the diagnostic criteria for FSHD rely on identifying the genetic signature of the disease (reduced D4Z4 allele, permissive 4q allele, hypomethylation, and in some cases variants in modifier genes). However, interpreting genetic data requires careful correlation with the phenotype, especially in atypical cases. The study included a cohort of 42 patients with a D4Z4 contraction or belonging to a pedigree in which DRAs segregated but who were selected due to presenting atypical clinical features or an unexpected disease severity according to the Comprehensive Clinical Evaluation Form (CCEF). The 42 underwent 4q subtype analysis, DNA methylation assessment, whole‐exome sequencing (WES) and segregation analysis. In 24 cases, WES identified likely pathogenic or pathogenic variants in genes associated with different neuromuscular disorders, in some cases possibly compatible with the observed phenotype. Methylation analysis proved useful in distinguishing asymptomatic and atypical cases, prompting differential diagnosis. Our results emphasize the importance of a detailed phenotypic characterization of patients with a suspicion of FSHD and, in the case of atypical phenotypes, the combination of D4Z4 sizing with other procedures such as WES.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
- Genomic Medicine Laboratory UILDM, IRCCS Fondazione Santa Lucia, Rome, Italy.
- Neuromuscular Unit, Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
- NeMO-Brescia Clinical Center for Neuromuscular Diseases, Brescia, Italy.
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Förderung
- the Italian Ministry for University and Research (MUR)
- Ministero dell'Università e della Ricerca
Zitieren
APA
Torri, F., Strafella, C., Vercelli, L., Gadaleta, G., Risi, B., Megalizzi, D., Colantoni, L., Ciurli, B., Rende, M., Filosto, M., Mongini, T., Siciliano, G., Giardina, E., & Ricci, G. (2026). The Role of Whole‐Exome Sequencing and Methylation Analysis in Untangling Complex Facioscapulo‐Humeral Muscular Dystrophy Cases. Clinical Genetics. https://doi.org/10.1111/cge.70044
Vancouver
Torri F, Strafella C, Vercelli L, Gadaleta G, Risi B, Megalizzi D, et al. The Role of Whole‐Exome Sequencing and Methylation Analysis in Untangling Complex Facioscapulo‐Humeral Muscular Dystrophy Cases. Clinical Genetics. 2026. doi:10.1111/cge.70044
BibTeX
@article{Torri2026,
author = {Torri, Francesca and Strafella, Claudia and Vercelli, Liliana and Gadaleta, Giulio and Risi, Barbara and Megalizzi, Domenica and Colantoni, Luca and Ciurli, Beatrice and Rende, Mariaconcetta and Filosto, Massimiliano and Mongini, Tiziana and Siciliano, Gabriele and Giardina, Emiliano and Ricci, Giulia},
title = {The Role of Whole‐Exome Sequencing and Methylation Analysis in Untangling Complex Facioscapulo‐Humeral Muscular Dystrophy Cases},
journal = {Clinical Genetics},
year = {2026},
doi = {10.1111/cge.70044}
}
EUVIMED